MustGrow Biologics Corp. MGROF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.04M | 71.60K | 621.40K | 573.00K | 226.10K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.04M | 71.60K | 621.40K | 573.00K | 226.10K |
| Cost of Revenue | 144.40K | 141.80K | 660.00K | 506.00K | 299.40K |
| Gross Profit | 894.60K | -70.20K | -38.60K | 66.90K | -73.30K |
| SG&A Expenses | 470.10K | 419.00K | 811.70K | 1.60M | 392.50K |
| Depreciation & Amortization | -- | -- | 9.60K | 9.70K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 678.30K | 651.00K | 1.56M | 2.23M | 750.70K |
| Operating Income | 360.80K | -579.40K | -943.00K | -1.65M | -524.60K |
| Income Before Tax | 298.40K | -635.30K | -1.51M | -1.76M | -681.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 298.40K | -635.30K | -1.51M | -1.76M | -681.50K |
| Earnings from Discontinued Operations | -92.70K | -329.00K | -- | -- | -105.60K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 205.70K | -964.30K | -1.51M | -1.76M | -787.00K |
| EBIT | 360.80K | -579.40K | -943.00K | -1.65M | -524.60K |
| EBITDA | 367.70K | -572.40K | -936.10K | -1.65M | -517.70K |
| EPS Basic | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| Normalized Basic EPS | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted | 0.00 | -0.02 | -0.03 | -0.03 | -0.02 |
| Normalized Diluted EPS | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 63.86M | 61.93M | 58.90M | 54.71M | 52.13M |
| Average Diluted Shares Outstanding | 63.86M | 61.93M | 58.90M | 54.71M | 52.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |